Hafrun Fridriksdottir
Net Worth

Last updated:

What is Hafrun Fridriksdottir net worth?

The estimated net worth of Dr. Hafrun Fridriksdottir is at least $18,832,055 as of 17 May 2022. He owns shares worth $24,255 as insider, has earned $2,777,800 from insider trading and has received compensation worth at least $16,030,000 in Teva Pharmaceutical Industries Limited.

What is the salary of Hafrun Fridriksdottir?

Dr. Hafrun Fridriksdottir salary is $2,290,000 per year as Executive Vice President of Global R&D in Teva Pharmaceutical Industries Limited.

How old is Hafrun Fridriksdottir?

Dr. Hafrun Fridriksdottir is 63 years old, born in 1962.

What stocks does Hafrun Fridriksdottir currently own?

As insider, Dr. Hafrun Fridriksdottir owns shares in one company:

Company Title Shares Price per share Total value
Teva Pharmaceutical Industries Limited (TEVA) Executive Vice President of Global R&D 1,386 $17.5 $24,255

What does Teva Pharmaceutical Industries Limited do?

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Hafrun Fridriksdottir insider trading

Teva Pharmaceutical Industries Limited

Dr. Hafrun Fridriksdottir has made 24 insider trades between 2018-2022, according to the Form 4 filled with the SEC. Most recently he sold 130,000 units of TEVA stock worth $1,068,080 on 17 May 2022.

The largest trade he's ever made was exercising 130,000 units of TEVA stock on 17 May 2022. As of 17 May 2022 he still owns at least 1,386 units of TEVA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Ordinary Shares 130,000 $8.22 $1,068,080
Option
Restricted Share Units 23,764 N/A N/A
Option
Restricted Share Units 18,905 N/A N/A
Option
Restricted Share Units 51,488 N/A N/A
Sale
Ordinary Shares 8,941 $7.37 $65,868
Option
Ordinary Shares 23,764 N/A N/A
Sale
Ordinary Shares 6,618 $7.48 $49,522
Option
Ordinary Shares 51,488 N/A N/A
Option
Ordinary Shares 18,905 N/A N/A
Sale
Ordinary Shares 18,020 $7.48 $134,844
Option
Ordinary Shares 21,682 N/A N/A
Option
Restricted Share Units 21,682 N/A N/A
Sale
Ordinary Shares 7,590 $8.14 $61,798
Sale
Ordinary Shares 6,116 $9.06 $55,411
Option
Restricted Share Units 16,121 N/A N/A
Option
Ordinary Shares 16,121 N/A N/A
Sale
Ordinary Shares 50,860 $9.95 $506,006
Option
Ordinary Shares 37,884 N/A N/A
Option
Restricted Share Units 37,884 N/A N/A
Sale
Ordinary Shares 19,066 $10.22 $194,835
Option
Ordinary Shares 18,905 N/A N/A
Sale
Ordinary Shares 9,515 $10.57 $100,535
Option
Restricted Share Units 18,905 N/A N/A
Sale
Ordinary Shares 50,000 $10.82 $540,900
Sale
Ordinary Shares 10,912 N/A N/A
Option
Ordinary Shares 21,682 N/A N/A
Option
Restricted Share Units 21,682 N/A N/A
Sale
Ordinary Shares 2,098 N/A N/A
Option
Restricted Share Units 5,355 N/A N/A
Option
Ordinary Shares 5,355 N/A N/A
Option
Ordinary Shares 16,120 N/A N/A
Sale
Ordinary Shares 29,496 N/A N/A
Option
Restricted Share Units 16,120 N/A N/A
Option
Ordinary Shares 1,014 N/A N/A
Sale
Ordinary Shares 514 N/A N/A
Option
Restricted Share Units 748 N/A N/A
Option
Ordinary Shares 23,203 N/A N/A
Option
Restricted Share Units 23,203 N/A N/A
Sale
Ordinary Shares 11,472 N/A N/A
Option
Restricted Share Units 23,203 N/A N/A
Option
Ordinary Shares 23,203 N/A N/A
Sale
Ordinary Shares 5,544 N/A N/A
Option
Ordinary Shares 16,120 N/A N/A
Option
Restricted Share Units 16,120 N/A N/A
Sale
Ordinary Shares 2,459 N/A N/A
Option
Ordinary Shares 4,640 N/A N/A
Option
Restricted Share Units 4,640 N/A N/A
Sale
Ordinary Shares 4,310 N/A N/A
Option
Restricted Share Units 8,133 N/A N/A
Option
Ordinary Shares 8,133 N/A N/A
Sale
Ordinary Shares 356 N/A N/A
Option
Restricted Share Units 1,012 N/A N/A
Option
Ordinary Shares 1,012 N/A N/A
Option
Restricted Share Units 1,165 N/A N/A
Sale
Ordinary Shares 409 N/A N/A
Option
Ordinary Shares 1,165 N/A N/A
Option
Ordinary Shares 5,353 N/A N/A
Option
Restricted Share Units 5,353 N/A N/A
Sale
Ordinary Shares 1,841 N/A N/A
Sale
Ordinary Shares 1,643 N/A N/A
Option
Ordinary Shares 4,640 N/A N/A
Option
Restricted Share Units 4,640 N/A N/A
Sale
Ordinary Shares 933 N/A N/A
Option
Restricted Share Units 2,711 N/A N/A
Option
Ordinary Shares 2,711 N/A N/A
Sale
Ordinary Shares 348 N/A N/A
Option
Ordinary Shares 1,012 N/A N/A
Option
Restricted Share Units 1,012 N/A N/A
Option
Restricted Share Units 3,432 N/A N/A
Option
Ordinary Shares 3,432 N/A N/A
Option
Ordinary Shares 1,165 N/A N/A
Option
Restricted Share Units 1,165 N/A N/A

Teva Pharmaceutical Industries Limited key executives

Teva Pharmaceutical Industries Limited executives and other stock owners filed with the SEC: